Apollo Hospitals Enterprise Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Apollo Hospitals Enterprise Limited, explained in plain English.

• ▪Apollo Hospitals Enterprise Limited is tracked in the Pharma & Healthcare sector of our NSE large-cap universe.
• ▪Reported fundamentals show a net margin of 7.91%, debt to equity of 85.15.
• ▪Our transparent MaxGrade checklist scores it F (33/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 19.14% with a maximum drawdown of -15.21% and a beta of 0.51 against NIFTY 50.
• ▪Recent coverage: Hospital stocks slip after SC query on steep cancer drug markups
• ▪Recent coverage: Market wrap: Kotak Mahindra Bank, InterGlobe, Apollo Hospital, Max Healthcare top gainers and losers on Nifty and Sensex on Wednesday
• ▪Recent coverage: Price Caps Not The Answer: Apollo Hospitals Eyes 100 Bps Cost Cut Amid Expansion

Figures from the current session. Market open.